Available to sourceHuman Prescription DrugGastrointestinal

Monobasic Sodium Phosphate and Dibasic Sodium Phosphate

Active ingredients · Sodium Phosphate Dibasic Anhydrous, Sodium Phosphate Monobasic Monohydrate

.398 g/1 / 1.105 g/1 · Tablet

By Lupin Pharmaceuticals,Inc.

NDC: 43386-030
Route: Oral
Therapeutic class: Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative
Marketing category: ANDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.